JP2000023673A - ヒト胃癌抗原遺伝子および胃癌抗原蛋白質 - Google Patents

ヒト胃癌抗原遺伝子および胃癌抗原蛋白質

Info

Publication number
JP2000023673A
JP2000023673A JP10197852A JP19785298A JP2000023673A JP 2000023673 A JP2000023673 A JP 2000023673A JP 10197852 A JP10197852 A JP 10197852A JP 19785298 A JP19785298 A JP 19785298A JP 2000023673 A JP2000023673 A JP 2000023673A
Authority
JP
Japan
Prior art keywords
gastric cancer
protein
amino acid
dna
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10197852A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000023673A5 (https=
Inventor
Kokichi Kikuchi
浩吉 菊地
Noriyuki Sato
昇志 佐藤
Toshihiko Torigoe
俊彦 鳥越
Hiromasu Sawara
弘益 佐原
Manabu Suzuki
学 鈴木
Junji Hamuro
淳爾 羽室
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to JP10197852A priority Critical patent/JP2000023673A/ja
Priority to US09/348,265 priority patent/US6444800B1/en
Priority to DE69927214T priority patent/DE69927214T2/de
Priority to AT99305469T priority patent/ATE304593T1/de
Priority to EP99305469A priority patent/EP0974653B1/en
Publication of JP2000023673A publication Critical patent/JP2000023673A/ja
Priority to US10/191,322 priority patent/US7030222B2/en
Publication of JP2000023673A5 publication Critical patent/JP2000023673A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP10197852A 1998-07-13 1998-07-13 ヒト胃癌抗原遺伝子および胃癌抗原蛋白質 Pending JP2000023673A (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP10197852A JP2000023673A (ja) 1998-07-13 1998-07-13 ヒト胃癌抗原遺伝子および胃癌抗原蛋白質
US09/348,265 US6444800B1 (en) 1998-07-13 1999-07-07 Human gastric cancer antigen gene and gastric cancer antigen protein
DE69927214T DE69927214T2 (de) 1998-07-13 1999-07-09 Menschliches Gen und Protein eines Magenkrebs-Antigens
AT99305469T ATE304593T1 (de) 1998-07-13 1999-07-09 Menschliches gen und protein eines magenkrebs- antigens
EP99305469A EP0974653B1 (en) 1998-07-13 1999-07-09 Human gastric cancer antigen gene and protein
US10/191,322 US7030222B2 (en) 1998-07-13 2002-07-10 Human gastric cancer antigen gene and gastric cancer antigen protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10197852A JP2000023673A (ja) 1998-07-13 1998-07-13 ヒト胃癌抗原遺伝子および胃癌抗原蛋白質

Publications (2)

Publication Number Publication Date
JP2000023673A true JP2000023673A (ja) 2000-01-25
JP2000023673A5 JP2000023673A5 (https=) 2005-07-28

Family

ID=16381418

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10197852A Pending JP2000023673A (ja) 1998-07-13 1998-07-13 ヒト胃癌抗原遺伝子および胃癌抗原蛋白質

Country Status (5)

Country Link
US (2) US6444800B1 (https=)
EP (1) EP0974653B1 (https=)
JP (1) JP2000023673A (https=)
AT (1) ATE304593T1 (https=)
DE (1) DE69927214T2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09151200A (ja) * 1995-09-29 1997-06-10 Ajinomoto Co Inc ヒト胃癌に対する免疫応答を誘導できるペプチド及び該ペプチドを含むヒト胃癌治療、予防剤
CA2504206A1 (en) * 2002-11-11 2004-05-27 Conocophillips Company Stabilized alumina supports, catalysts made therefrom, and their use in partial oxidation
KR101408173B1 (ko) 2006-06-16 2014-06-16 온코세라피 사이언스 가부시키가이샤 Ｓｐａｒｃ 유래의 암 거절항원 펩티드 및 이를 포함하는 의약
DE102023001827A1 (de) 2023-04-19 2024-10-24 Horst Wochnowski Verfahren und dazugehörige Vorrichtung zum Züchten von in Gewässern Mikroplastik zersetzenden und abbauenden Mikroorganismenstämme durch einen künstlich herbeigeführten und beschleunigten Evolutions- und Selektionsprozess

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09151200A (ja) * 1995-09-29 1997-06-10 Ajinomoto Co Inc ヒト胃癌に対する免疫応答を誘導できるペプチド及び該ペプチドを含むヒト胃癌治療、予防剤
US5932442A (en) 1997-09-23 1999-08-03 Incyte Pharmaceuticals, Inc. Human regulatory molecules
AU3395900A (en) 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides

Also Published As

Publication number Publication date
ATE304593T1 (de) 2005-09-15
DE69927214T2 (de) 2006-07-06
US20020173642A1 (en) 2002-11-21
EP0974653A3 (en) 2001-09-19
EP0974653A2 (en) 2000-01-26
EP0974653B1 (en) 2005-09-14
US6444800B1 (en) 2002-09-03
US7030222B2 (en) 2006-04-18
DE69927214D1 (de) 2005-10-20

Similar Documents

Publication Publication Date Title
KR101050703B1 (ko) Ｈｌａ-ａ24-구속성 암 항원 펩티드
US8535690B2 (en) Tumor specific animal proteins
EP1306431B1 (en) Tumor antigen
CA2334038A1 (en) Compositions and methods for therapy and diagnosis of prostate cancer
JP2002540790A (ja) 肺癌の治療および診断のための化合物ならびにその使用のための方法
JP2002543769A (ja) 肺癌の治療および診断のための化合物および方法
JPWO2002010369A1 (ja) 腫瘍抗原
KR100581508B1 (ko) 종양항원 펩티드 유도체
KR20020007348A (ko) 유방암의 치료 및 진단용 조성물 및 이의 사용 방법
US20040126362A1 (en) Compositions and methods for WT1 specific immunotherapy
JP2002538074A (ja) Ｎｙ−ｅｓｏ−１のアミノ酸配列に対応し、かつｍｈｃクラスｉ分子及びｍｈｃクラスｉｉ分子に結合する単離ペプチドおよびその利用方法
JP4436977B2 (ja) 新規な腫瘍抗原タンパク質ｓａｒｔ−３、およびその腫瘍抗原ペプチド
JPWO2000012701A1 (ja) 新規な腫瘍抗原タンパク質ｓａｒｔ−３、およびその腫瘍抗原ペプチド
JP2002540789A (ja) 乳癌の処置および診断のための組成物ならびにそれらの使用方法
JP2000023673A (ja) ヒト胃癌抗原遺伝子および胃癌抗原蛋白質
CN100430478C (zh) Casb618多核苷酸和多肽及其用途
WO2002050103A2 (en) Tumour-related antigens
KR102397922B1 (ko) 신규한 종양-관련 항원 단백질 olfm4 및 이의 용도
WO2002006338A1 (en) Vaccine comprising a lung tumour associated antigen
JP2003526320A (ja) 複数の腫瘍において過剰発現される抗原ｃａｓｂ４１４
WO2001057077A1 (en) Proteins that are specifically expressed or highly overexpressed in tumors and nucleic acids encoding them
JPWO2000006595A1 (ja) Ｓａｒｔ−１由来のｈｌａ−ａ２拘束性腫瘍抗原ペプチド
JPWO2000002907A1 (ja) Ｓａｒｔ−１由来の腫瘍抗原ペプチド
HK1052710B (en) Novel compounds

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20041222

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20041222

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20061121

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070320